Pancreatoduodenal carcinoma: a clinicopathologic study of 304 patients and immunohistochemical observation for CEA and CA19-9

作者: Koji Yamaguchi , Munetomo Enjoji , Masazumi Tsuneyoshi

DOI: 10.1002/JSO.2930470303

关键词:

摘要: A total of 304 patients with pancreatoduodenal carcinoma were studied clinicopathologically and immunohistochemically in order to clarify features four different sites origin; the ampulla Vater (Am), distal common bile duct (DCBD), head pancreas (PH), extra-ampullary duodenum (Du). The mean greatest diameter 87 PH was 3.5 cm compared 2.7 149 Am DCBD. Histopathologically, 40% papillary adenocarcinoma, while about half DCBD, Du tubular adenocarcinoma. invaded lymphatic (85%), vascular (62%), perineural (95%) spaces metastasized lymph nodes (72%) more frequently than (77%, 35%, 24%, 50%), DCBD (47%, 61%, 65%, 45%), (76%, 29%, 65%), respectively. More 50% resected margins, whereas only 2% Am, surgical margins affected by malignant cells. Immunohistochemically, positive for both carcinoembryonic antigen (CEA) (98%) carbohydrate (CA) 19-9 (91%) (83%, 62%), (94%, 58%), (56%, 11%), stromal staining type CEA CA seen (27%, 44%) (9%, 31%), (11%, 8%) (0%, 0%), showing a dedifferentiated nature PH. cumulative 3-year survival rate (15%) worse that (42%, P less 0.001), 51 (25%) 17 (58%, 0.001). curve (P 0.001) Cox regression analysis, using eleven profound prognostic variables, revealed venous invasion, infiltration, margin, histopathologic factors. Pancreatic has nature, aggressive growth fares Du.

参考文章(20)
Leslie Wise, Carlos Pizzimbono, Louis P. Dehner, Periampullary cancer: A clinicopathologic study of sixty-two patients American Journal of Surgery. ,vol. 131, pp. 141- 148 ,(1976) , 10.1016/0002-9610(76)90087-8
William M. Steinberg, Richard Gelfand, Kimberly K. Anderson, Jerry Glenn, Scott H. Kurtzman, William F. Sindelar, Philip P. Toskes, Comparison of the sensitivity and specificity of the CA19-9 and carcinoembryonic antigen assays in detecting cancer of the pancreas. Gastroenterology. ,vol. 90, pp. 343- 349 ,(1986) , 10.1016/0016-5085(86)90930-3
Koji Yamaguchi, Munetomo Enjoji, Cystic neoplasms of the pancreas Gastroenterology. ,vol. 92, pp. 1934- 1943 ,(1987) , 10.1016/0016-5085(87)90627-5
Yoshinori Hamada, Manabu Yamamura, Kohshiro Hioki, Masakatsu Yamamoto, Hiroshi Nagura, Keiichi Watanabe, Immunohistochemical study of carcinoembryonic antigen in patients with colorectal cancer. Correlation with plasma carcinoembryonic antigen levels Cancer. ,vol. 55, pp. 136- 141 ,(1985) , 10.1002/1097-0142(19850101)55:1<136::AID-CNCR2820550121>3.0.CO;2-P
Harumi Sakahara, Keigo Endo, Kotoko Nakajima, Tetsuo Nakashima, Mitsuru Koizumi, Hitoya Ohta, Akinari Hidaka, Shigene Kohno, Yoshihisa Nakano, Atsushi Naito, Takashi Suzuki, Kanji Torizuka, Serum CA 19‐9 concentrations and computed tomography findings in patients with pancreatic carcinoma Cancer. ,vol. 57, pp. 1324- 1326 ,(1986) , 10.1002/1097-0142(19860401)57:7<1324::AID-CNCR2820570712>3.0.CO;2-A
M. Dietel, H. Arps, R. Klapdor, S. M�ller-Hagen, M. Sieck, L. Hoffmann, Antigen detection by the monoclonal antibodies CA 19-9 and CA 125 in normal and tumor tissue and patients' sera Journal of Cancer Research and Clinical Oncology. ,vol. 111, pp. 257- 265 ,(1986) , 10.1007/BF00389242
Giuseppe Del Favero, Carlo Fabris, Mario Plebani, Aldo Panucci, Antonio Piccoli, Laura Perobelli, Sergio Pedrazzoli, Ugo Baccaglini, Angelo Burlina, Remo Naccarato, CA 19-9 and carcinoembryonic antigen in pancreatic cancer diagnosis. Cancer. ,vol. 57, pp. 1576- 1579 ,(1986) , 10.1002/1097-0142(19860415)57:8<1576::AID-CNCR2820570823>3.0.CO;2-9
Thomas Winek, Daniel Hamre, Everett Mozell, R. Mark Vetto, Prognostic factors for survival after pancreaticoduodenectomy for malignant disease American Journal of Surgery. ,vol. 159, pp. 454- 456 ,(1990) , 10.1016/S0002-9610(05)81244-9